470
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission

, , , , , & show all
Pages 1069-1074 | Received 16 Dec 2015, Accepted 01 Feb 2016, Published online: 19 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Anuja Pandey, Lea Achrafie, Petya Kodjamanova, Tom Tencer & Jinender Kumar. (2022) Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes. Current Medical Research and Opinion 38:9, pages 1531-1541.
Read now
João Carlos Silva, Carlos Fernandes, Jaime Rodrigues, Sónia Fernandes, Ana Ponte, Adélia Rodrigues, Ana Paula Silva, Ana Catarina Gomes, Edgar Afecto, João Correia & João Carvalho. (2020) Endoscopic and histologic activity assessment considering disease extent and prediction of treatment failure in ulcerative colitis. Scandinavian Journal of Gastroenterology 55:10, pages 1157-1162.
Read now

Articles from other publishers (26)

Feng Gao, Qifu He, Shenghui Wu, Kang Zhang, Zhiming Xu, Jian Kang & Fusheng Quan. (2023) Catalpol ameliorates LPS-induced inflammatory response by activating AMPK/mTOR signaling pathway in rat intestinal epithelial cells. European Journal of Pharmacology 960, pages 176125.
Crossref
Ajit Sood, Arshdeep Singh, Ramit Mahajan, Vandana Midha, Charles N Bernstein & David T Rubin. (2023) (Re)Appraising Remission in Ulcerative Colitis. Inflammatory Bowel Diseases 29:8, pages 1317-1326.
Crossref
Yukie Hayashi, Kaoru Takabayashi, Motohiko Kato, Anna Tojo, Yasuhiro Aoki, Yuya Hagihara, Kosuke Yoshida, Yusuke Yoshimatsu, Hiroki Kiyohara, Shinya Sugimoto, Kosaku Nanki, Yohei Mikami, Tomohisa Sujino, Makoto Mutaguchi, Takaaki Kawaguchi, Naoki Hosoe, Naohisa Yahagi, Haruhiko Ogata & Takanori Kanai. (2023) Usefulness of texture and color enhancement imaging in assessing mucosal healing in patients with ulcerative colitis. Gastrointestinal Endoscopy 97:4, pages 759-766.e1.
Crossref
Angelo Viscido, Marco Valvano, Gianpiero Stefanelli, Annalisa Capannolo, Chiara Castellini, Eugenia Onori, Antonio Ciccone, Filippo Vernia & Giovanni Latella. (2022) Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis. BMC Gastroenterology 22:1.
Crossref
Kunio Asonuma, Taku Kobayashi, Masaru Nakano, Shintaro Sagami, Hiroki Kiyohara, Mao Matsubayashi, Hiromu Morikubo, Yusuke Miyatani, Shinji Okabayashi, Hajime Yamazaki, Yuichiro Kuroki & Toshifumi Hibi. (2022) Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis. Inflammatory Bowel Diseases 28:2, pages 200-207.
Crossref
Artin Soroosh, Kai Fang, Jill M. Hoffman, Ivy K. M. Law, Elizabeth Videlock, Zulfiqar A. Lokhandwala, Jonathan J. Zhao, Sepehr Hamidi, David M. Padua, Mark R. Frey, Charalabos Pothoulakis & Carl R. Rankin. (2021) Loss of miR-24-3p promotes epithelial cell apoptosis and impairs the recovery from intestinal inflammation. Cell Death & Disease 13:1.
Crossref
Panu Wetwittayakhlang, Livia Lontai, Lorant Gonczi, Petra A. Golovics, Gustavo Drügg Hahn, Talat Bessissow & Peter L. Lakatos. (2021) Treatment Targets in Ulcerative Colitis: Is It Time for All In, including Histology?. Journal of Clinical Medicine 10:23, pages 5551.
Crossref
Jongwook Yu, Jihye Park, Eun Ae Kang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Won Ho Kim & Jae Hee Cheon. (2021) Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis. Gut and Liver 15:6, pages 858-866.
Crossref
Carsten SchmidtOliver Bachmann, Daniel C. Baumgart, Martin Goetz, Oliver Drvarov, Torsten F. Kucharzik, Tanja Kühbacher, Jost Langhorst, Jochen Maul, Wolfgang Mohl, Jonas Mudter, Michael Repp, Andreas Sturm, Dieter Witzemann & Raja Atreya. (2021) Positionspapier zur Befunderstellung endoskopischer Untersuchungen bei Patienten mit chronisch-entzündlichen Darmerkrankungen. Zeitschrift für Gastroenterologie 59:10, pages 1091-1109.
Crossref
Iril Lovise Monstad, Inger Camilla Solberg, Milada Cvancarova, Oistein Hovde, Magne Henriksen, Gert Huppertz-Hauss, Eva Gunther, Bjørn Allan Moum, Njaal Stray, Morten Vatn, Ole Hoie & Jørgen Jahnsen. (2021) Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study. Journal of Crohn's and Colitis 15:6, pages 969-979.
Crossref
Xiaotian Xu, Chengqiong Wei, Yingying Yang, Meng Liu, Ailin Luo, Hengzhi Song, Yuhui Wang & Xiaoqun Duan. (2021) New discovery of anti-ulcerative colitis active ingredients of Nostoc commune: p-Hydroxy benzaldehyde. Journal of Functional Foods 77, pages 104327.
Crossref
Hyuk Yoon, Sushrut Jangi, Parambir S. Dulai, Brigid S. Boland, Larry J. Prokop, Vipul Jairath, Brian G. Feagan, William J. Sandborn & Siddharth Singh. (2020) Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis. Gastroenterology 159:4, pages 1262-1275.e7.
Crossref
Giulia D’Arcangelo & Marina Aloi. (2020) Treat-to-Target in Pediatric Inflammatory Bowel Disease: What Does the Evidence Say?. Pediatric Drugs 22:5, pages 463-472.
Crossref
Clara Yzet, Momar Diouf, Jean-Philippe Le Mouel, Franck Brazier, Justine Turpin, Julien Loreau, Jean Louis Dupas, Laurent Peyrin-Biroulet & Mathurin Fumery. (2020) Complete Endoscopic Healing Associated With Better Outcomes Than Partial Endoscopic Healing in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology 18:10, pages 2256-2261.
Crossref
Sushrut Jangi, Hyuk Yoon, Parambir S. Dulai, Mark Valasek, Brigid S. Boland, Vipul Jairath, Brian G. Feagan, William J. Sandborn & Siddharth Singh. (2020) Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing. Alimentary Pharmacology & Therapeutics.
Crossref
Jimmy K. Limdi, Michael Picco & Francis A. Farraye. (2020) A review of endoscopic scoring systems and their importance in a treat-to-target approach in inflammatory bowel disease (with videos). Gastrointestinal Endoscopy 91:4, pages 733-745.
Crossref
Manasi Agrawal & Jean-Frederic Colombel. (2019) Treat-to-Target in Inflammatory Bowel Diseases, What Is the Target and How Do We Treat?. Gastrointestinal Endoscopy Clinics of North America 29:3, pages 421-436.
Crossref
Ryan Ungaro, Jean-Frédéric Colombel, Trevor Lissoos & Laurent Peyrin-Biroulet. (2019) A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review. American Journal of Gastroenterology 114:6, pages 874-883.
Crossref
Keita Fukaura, Yoichiro Iboshi, Haruei Ogino, Eikichi Ihara, Kazuhiko Nakamura, Yuichiro Nishihara, Kei Nishioka, Takatoshi Chinen, Tsutomu Iwasa, Akira Aso, Ayako Goto, Kazuhiro Haraguchi, Hirotada Akiho, Naohiko Harada & Yoshihiro Ogawa. (2019) Mucosal Profiles of Immune Molecules Related to T Helper and Regulatory T Cells Predict Future Relapse in Patients With Quiescent Ulcerative Colitis. Inflammatory Bowel Diseases 25:6, pages 1019-1027.
Crossref
Ji Young Chang, Jae Hee Cheon, Yehyun Park, Soo Jung Park, Tae-Il Kim & Won-Ho Kim. (2018) Does Medical Acceleration Improve Outcomes in Ulcerative Colitis Patients Who Are in Clinical Remission but Have Endoscopic Inflammation?. Digestive Diseases and Sciences 63:11, pages 3041-3048.
Crossref
Christopher Ma, Remo Panaccione, Richard N. Fedorak, Claire E. Parker, Tran M. Nguyen, Reena Khanna, Corey A. Siegel, Laurent Peyrin-Biroulet, Geert D’Haens, William J. Sandborn, Brian G. Feagan & Vipul Jairath. (2018) Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set. Clinical Gastroenterology and Hepatology 16:5, pages 637-647.e13.
Crossref
Ji Young Chang & Jae Hee Cheon. (2018) Fecal Immunochemical Test and Fecal Calprotectin Measurement Are Noninvasive Monitoring Tools for Predicting Endoscopic Activity in Patients with Ulcerative Colitis. Gut and Liver 12:2, pages 117-118.
Crossref
Takayuki Yamamoto, Takahiro Shimoyama, Satoru Umegae & Koichi Matsumoto. (2018) Endoscopic score vs. fecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healing. Clinical and Translational Gastroenterology 9:3, pages e136.
Crossref
Glen Doherty, Konstantinos H Katsanos, Johan Burisch, Matthieu Allez, Konstantinos Papamichael, Andreas Stallmach, Ren Mao, Ingrid Prytz Berset, Javier P Gisbert, Shaji Sebastian, Jarosław Kierkuś, Loris Lopetuso, Edyta Szymanska & Edouard Louis. (2018) European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 12:1, pages 17-31.
Crossref
Ana Ponte, Rolando Pinho, Sónia Fernandes, Adélia Rodrigues, Luís Alberto, João Carlos Silva, Joana Silva, Jaime Rodrigues, Mafalda Sousa, Ana Paula Silva, Luísa Proença, Teresa Freitas, Sónia Leite & João Carvalho. (2017) Impact of Histological and Endoscopic Remissions on Clinical Recurrence and Recurrence-free Time in Ulcerative Colitis. Inflammatory Bowel Diseases 23:12, pages 2238-2244.
Crossref
Julian Panes, Vipul Jairath & Barrett G. Levesque. (2017) Advances in Use of Endoscopy, Radiology, and Biomarkers to Monitor Inflammatory Bowel Diseases. Gastroenterology 152:2, pages 362-373.e3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.